Home Your basket
• Thyroid papillary microca...
   Price 10.50 €
• Reconstruction of bone de...
   Price 10.50 €
• Recurrences of pleomorphi...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Middle ear overpressure w...
   Price 10.50 €
• Congenital anomalies of n...
   Price 14.00 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• Evaluation of quality of ...
   Price 10.50 €
• Therapeutic education of ...
   Price 12.50 €
• Enlarged marginal incisio...
   Price 10.50 €
• Voice rehabilitation afte...
   Price 10.50 €
• The nasal framework in rh...
   Price 10.50 €
• Management of a huge amel...
   Price 5.50 €
• Notes on voice and speech...
   Price 8.50 €
• Peptide receptor radionuc...
   Price 14.00 €
• Side effects and patients...
   Price 10.50 €
• ...
   Price 5.50 €
• Papillary thyroid microca...
   Price 10.50 €
• Disorders of the sense of...
   Price 5.50 €
• Tuberculous otomastoiditi...
   Price 5.50 €
• Interest of the chest CT ...
   Price 10.50 €
• Functional comparison of ...
   Price 14.00 €
• Mast cells in chronic inf...
   Price 10.50 €
• Vocal forcing and posture...
   Price 10.50 €
• Therapeutic management of...
   Price 10.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• Cosmetic radiofrequency...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Characteristics of the ma...
   Price 12.50 €
• Description of complicati...
   Price 5.50 €

Total Order 293.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 1999 o

CERVICO-FACIAL CARCINOLOGY

Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence ?


Authors : G. Dolivet, P. Colosetti, J. L. Merlin, Cl. Depardieu, M. Lapeyre, E. Wattel, J. Sarini, J. Ton Van, L. Geoffrois, Ph. Lagarde (Vandoeuvre les Nancy)

Ref. : Rev Laryngol Otol Rhinol 1999;120,1:5-12.

Article published in french



Summary : The study of epidemiology and of the carcinogenesis in epidermoid carcinomas of the upper aerodigestive tract shows that their occurrence is not random. Tobacco abuse plays a major role, especially because of benzopyrene, mutagen of the P53 gene, however it is associated with many other potentiating factors : alcohol, metals, hydrocarbures, virus, food, climate, genetic fragility that create genetic lesions at the origin of carcinogenesis. The latter occurs as "field cancerization" with multiple alterations of the mucosa and general attack of the control systems of the differentiation, growth and cell apoptosis which usually protect the cell against the phenomena of carcinogenesis. The P53 protein gene, retinoid receptors as well as the system of detoxifying glutathion S transferase are modified at the very early stage of these diseases, these abnormalities can be logically related to epidemiological data. These date lead us therefore to imagine complementary specific reverting therapies of induced genetic abnormalities, through the reexpression of non mutated gene encoding P53 protein and the use of retinoid. These various modalities are reported hereafter.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE